To determine if plasma circulating HPV DNA (cHPVDNA) has potential as a non-invasive biomarker for identification and treatment monitoring of cervical intraepithelial neoplasia grades 2-3 by characterizing correlation between plasma cHPVDNA levels and cervical intraepithelial neoplasia grade prior to intervention and after excision.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
Radiation Oncology - Chapel Hill
Clinical or Medical
Sexual and/or Reproductive Health